Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier.
about
Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.Cell cycle proteins as promising targets in cancer therapyInvestigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016).Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part II.Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme.Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
P2860
Q36161900-3A6CB118-9B5F-45E3-8F51-7A356D3E119BQ37693690-992DF0CA-B202-4498-91C0-A69B415EE10BQ38949247-18708FE4-1C3D-4919-AB66-4F4826A20C90Q39166795-18F492EA-0E6D-49A0-9E95-4AFA24997C0CQ39166808-CF24CB1E-B383-454C-8F78-54FE181B6AB5Q39190733-24F6C119-D50B-46E9-926E-9E88A1D80D91Q52671034-88E6692D-3E5A-4221-BB95-906050AC2D57
P2860
Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-tumour efficacy on glioma ...... cross the blood-brain barrier.
@en
Anti-tumour efficacy on glioma ...... cross the blood-brain barrier.
@nl
type
label
Anti-tumour efficacy on glioma ...... cross the blood-brain barrier.
@en
Anti-tumour efficacy on glioma ...... cross the blood-brain barrier.
@nl
prefLabel
Anti-tumour efficacy on glioma ...... cross the blood-brain barrier.
@en
Anti-tumour efficacy on glioma ...... cross the blood-brain barrier.
@nl
P2093
P2860
P356
P1476
Anti-tumour efficacy on glioma ...... cross the blood-brain barrier.
@en
P2093
A Degrassi
C Albanese
C Festuccia
C Mercurio
F Fiorentini
P2860
P304
P356
10.1111/BPH.12112
P407
P577
2013-05-01T00:00:00Z